Fennec Pharmaceuticals (FENC) Receivables - Net (2022 - 2025)
Fennec Pharmaceuticals (FENC) has disclosed Receivables - Net for 4 consecutive years, with $19.3 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Receivables - Net rose 49.85% year-over-year to $19.3 million, compared with a TTM value of $19.3 million through Sep 2025, up 49.85%, and an annual FY2024 reading of $12.9 million, up 46.18% over the prior year.
- Receivables - Net was $19.3 million for Q3 2025 at Fennec Pharmaceuticals, up from $17.5 million in the prior quarter.
- Across five years, Receivables - Net topped out at $19.3 million in Q3 2025 and bottomed at $1.5 million in Q4 2022.
- Average Receivables - Net over 4 years is $10.0 million, with a median of $11.3 million recorded in 2024.
- The sharpest move saw Receivables - Net skyrocketed 510.46% in 2024, then soared 42.15% in 2025.
- Year by year, Receivables - Net stood at $1.5 million in 2022, then skyrocketed by 470.49% to $8.8 million in 2023, then soared by 46.18% to $12.9 million in 2024, then soared by 50.13% to $19.3 million in 2025.
- Business Quant data shows Receivables - Net for FENC at $19.3 million in Q3 2025, $17.5 million in Q2 2025, and $15.4 million in Q1 2025.